Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanju Sinha

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Bioengineering (Basel, Switzerland)|January 28, 2026
PathQC: Determining Molecular and Structural Integrity of Tissues from Histopathological SlidesRanjit Kumar Sinha, Anamika Yadav, Sanju Sinha
Nature Reviews. Cancer|September 5, 2022
Big data in basic and translational cancer researchPeng Jiang, Sanju Sinha, Kenneth Aldape, et al.
Cell Reports Methods|March 17, 2026
Tissue morphology predicts telomere shortening in human tissuesAnamika Yadav, Kyle Alvarez, Akanimoh Adeleye, et al.
Molecular Systems Biology|July 31, 2020
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expressionSanju Sinha, Kuoyuan Cheng, Alejandro A Schäffer, et al.
Genome Biology|February 28, 2025
PRODE recovers essential and context-essential genes through neighborhood-informed scoresThomas Cantore, Paola Gasperini, Riccardo Bevilacqua, et al.
Biorxiv : the Preprint Server for Biology|February 15, 2023
Predicting tumor immune microenvironment and checkpoint therapy response of head & neck cancer patients from blood immune single-cell transcriptomicsYingying Cao, Tiangen Chang, Fiorella Schischlik, et al.
Cancer Research Communications|August 8, 2024
Inferring Characteristics of the Tumor Immune Microenvironment of Patients with HNSCC from Single-Cell Transcriptomics of Peripheral BloodYingying Cao, Tiangen Chang, Fiorella Schischlik, et al.
Cancers|October 14, 2023
Pan-Cancer Analysis of Patient Tumor Single-Cell Transcriptomes Identifies Promising Selective and Safe Chimeric Antigen Receptor Targets in Head and Neck CancerSanna Madan, Sanju Sinha, Tiangen Chang, et al.
Nature Communications|March 26, 2022
The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspectiveSaba Ahmadi, Pattara Sukprasert, Rahulsimham Vegesna, et al.
JCO Precision Oncology|January 7, 2022
Using a Recently Approved Tumor Mutational Burden Biomarker to Stratify Patients for Immunotherapy May Introduce a Sex BiasNeelam Sinha, Sanju Sinha, Kuoyuan Cheng, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Bioengineering (Basel, Switzerland)|January 28, 2026
PathQC: Determining Molecular and Structural Integrity of Tissues from Histopathological SlidesRanjit Kumar Sinha, Anamika Yadav, Sanju Sinha
Nature Reviews. Cancer|September 5, 2022
Big data in basic and translational cancer researchPeng Jiang, Sanju Sinha, Kenneth Aldape, et al.
Cell Reports Methods|March 17, 2026
Tissue morphology predicts telomere shortening in human tissuesAnamika Yadav, Kyle Alvarez, Akanimoh Adeleye, et al.
Molecular Systems Biology|July 31, 2020
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expressionSanju Sinha, Kuoyuan Cheng, Alejandro A Schäffer, et al.
Genome Biology|February 28, 2025
PRODE recovers essential and context-essential genes through neighborhood-informed scoresThomas Cantore, Paola Gasperini, Riccardo Bevilacqua, et al.
Biorxiv : the Preprint Server for Biology|February 15, 2023
Predicting tumor immune microenvironment and checkpoint therapy response of head & neck cancer patients from blood immune single-cell transcriptomicsYingying Cao, Tiangen Chang, Fiorella Schischlik, et al.
Cancer Research Communications|August 8, 2024
Inferring Characteristics of the Tumor Immune Microenvironment of Patients with HNSCC from Single-Cell Transcriptomics of Peripheral BloodYingying Cao, Tiangen Chang, Fiorella Schischlik, et al.
Cancers|October 14, 2023
Pan-Cancer Analysis of Patient Tumor Single-Cell Transcriptomes Identifies Promising Selective and Safe Chimeric Antigen Receptor Targets in Head and Neck CancerSanna Madan, Sanju Sinha, Tiangen Chang, et al.
Nature Communications|March 26, 2022
The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspectiveSaba Ahmadi, Pattara Sukprasert, Rahulsimham Vegesna, et al.
JCO Precision Oncology|January 7, 2022
Using a Recently Approved Tumor Mutational Burden Biomarker to Stratify Patients for Immunotherapy May Introduce a Sex BiasNeelam Sinha, Sanju Sinha, Kuoyuan Cheng, et al.
Pageof 5